English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

:  (Huntington disease [HD] chorea)         . : 2011 2       .   :  ,      tetrabenazine (100 mg/day ), (amantadine) (300~400 mg/day),  riluzole (200 mg/day) (Level B)  .    ,  tetrabenazine    /, riluzole        .   (United Huntington’s Disease Rating Scale [UHDRS] chorea  1 2  )  nabilone   (Level C),        (Level U). (2 3  UHDRS chorea )   (Level B)  (3)     riluzole 100 mg/day   (Level B).   (UHDRS chorea 3  )  ethyl-EPA (Level B), (minocycline) (Level B)  (creatine) (Level C)   .    Q10 (coenzyme Q10) (Level B)  .      (donepezil)     (Level U).

neurology

Evidence-based guideline: Pharmacologic treatment of chorea in Huntington disease: Report of the Guideline Development Subcommittee of the American Academy of Neurology